In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Pharma R&D Efficiency: Mid-Sized Companies Excel

Executive Summary

Datamonitor Healthcare's recent review of R&D efficiency using new product launch success rates as a proxy shows that Mid Pharma companies outperform Big Pharma and Japan Pharma firms, thanks to multiple blockbuster drugs. The first in a two-part series evaluating R&D productivity.

Advertisement

Related Content

Mid Pharma Companies Show Strength In Dealmaking
When It Comes To Pharma R&D ROI, Mid Pharma Companies Outperform
Clinical Trial Success Rates Still Dismal, But Certain Sectors Outperform

Topics

Related Companies

UsernamePublicRestriction

Register